title: Progesterone antagonizes development but not maintenance of ACTH-induced hypertension in sheep.
abstract: 1. This study investigated the effect of progesterone, which, under certain circumstances, can antagonize both the mineralocorticoid and glucocorticoid activities of steroid hormones, on the development and maintenance of adrenocorticotrophic hormone (ACTH)-induced hypertension in conscious sheep. 2. Progesterone (500 mg/day) alone, for 5 days, had no effect on blood pressure, but increased urinary Na excretion by 38 +/- 10 mmol/day (P less than 0.05) during the first 24 h. 3. Infusion of ACTH (5 micrograms/kg per day), alone, for 3 days, increased arterial pressure by 21 +/- 2 mmHg (P less than 0.001) associated with hypernatraemia, hypokalaemia, urinary Na retention, and increased fasting plasma glucose concentration. 4. Progesterone (500 mg/day) concurrently with ACTH blocked the rise in mean arterial pressure and the mineralocorticoid (urinary Na retention) but not the glucocorticoid (increase in plasma glucose concentration) effects associated with ACTH administration. 5. Progesterone (500 and 1000 mg/day) failed to reverse the hypertension and hypokalaemia in sheep pretreated for 3 days with ACTH. 6. Thus, progesterone blocked the onset but did not affect established ACTH hypertension. The mechanism by which progesterone blocked the development of ACTH hypertension appears to be related to the ability of progesterone to block the essential mineralocorticoid component of the adrenocortical steroids involved in the development of ACTH hypertension.
authors.affiliation: Howard Florey Institute of Experimental Physiology and Medicine, Parkville, Victoria, Australia.
authors.forename: C D
authors.initials: CD
authors.lastname: Spence
authors.forename: A F
authors.initials: AF
authors.lastname: Reid
authors.forename: J P
authors.initials: JP
authors.lastname: Coghlan
authors.forename: E H
authors.initials: EH
authors.lastname: Mills
authors.forename: J A
authors.initials: JA
authors.lastname: Whitworth
authors.forename: B A
authors.initials: BA
authors.lastname: Scoggins
mesh_terms: D000324:Adrenocorticotropic Hormone / Q000037:antagonists & inhibitors*; D000450:Aldosterone / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D005260:Female; D006973:Hypertension / Q000139:chemically induced / Q000503:physiopathology*; D007262:Infusions, Intravenous; D010052:Ovariectomy; D011188:Potassium / Q000378:metabolism; D011374:Progesterone / Q000494:pharmacology*; D012463:Saliva / Q000378:metabolism; D012756:Sheep; D012964:Sodium / Q000378:metabolism; D013997:Time Factors
chemical_list: D000450:Aldosterone; D011374:Progesterone; D000324:Adrenocorticotropic Hormone; D012964:Sodium; D011188:Potassium